-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
After examination by the State Drug Administration, a Shenzhen company's application for registration of innovative products for the treatment of abdominal aneurysms or total aneurysms.
this is the 100th innovative medical device approved for market since the State Drug Administration set up a fast approval channel for innovative medical devices.
Since the opening of the "Green Channel" for innovative medical devices in 2014, as of the end of December 2020, 1,471 product applications have entered the Innovation Channel, and 292 products have been incorporated into the Channel as innovative medical devices, accounting for about 20% of all applications.
, 100 innovative medical devices have been approved for the market.
of these 100 products, 96 are domestic products, involving 78 medical device enterprises in 14 provinces, autonomous regions and municipalities directly under the Central Government (of which 17 are in-body diagnostic enterprises), accounting for 96% of all products, 4 imported products, involving 4 enterprises in two countries.
the location of approved products, the number of innovative medical devices in industrial provinces ranked highest, 25 in Beijing, 19 in Shanghai, 17 in Guangdong and 14 in Jiangsu.
from the product characteristics, 43 active devices, 37 passive devices, in-body diagnostic reagents and equipment 20.